GLP-1 receptor agonists (GLP-1) are medications designed to help individuals lose weight
Certain clinics report as much as a 20 percent improvement in skin tightness post-series, although outcomes may vary based on skin condition and treatment intensity
Hepatic glucagon increases gluconeogenesis and lipolysis via PKA/CREB activation, stimulates brown adipose tissue thermogenesis, and reduces hepatic triglyceride accumulation
MTC is very rare, accounting for only about 1% to 3% of all thyroid cancer cases in the UK
This analysis is based on Planet Fitness Q4 2025 earnings releases and call transcripts, Life Time Group Holdings 8-K filings and earnings call transcripts, the Ro press release announcing the Serena Williams partnership, Athletech News, CNBC, Bloomberg, NBC News, the New England Journal of Medicine, Morgan Stanley Research notes on GLP-1 consumer impact, and reporting from Quartz, Fast Company, and the Boring Business Nerd newsletter